Newspaper Publication for the unaudited financial results (Standalone and consolidated) for the Quarter ended December 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech Limited has informed BSE about the newspaper publication of its unaudited standalone and consolidated financial results for the quarter ended December 31, 2025. The company's Board of Directors approved these results at a meeting held on February 26, 2026. The results were subsequently published on February 28, 2026 in Trinity Mirror (English) and Makkal Kural (Tamil), in compliance with SEBI's Listing Regulations. The full financial results along with the Limited Review Report have been posted on the company's investor relations webpage (indrayani.com/investor-relations) and can also be accessed via a QR code.
This is a routine regulatory disclosure with no direct impact on shareholders or the stock price. Investors who want to review the actual Q3 performance numbers should check the unaudited financial results and Limited Review Report available on the company's website.